Terms: = Breast cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Treatment
237 results:
1. Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancer.
Eiro N; Fraile M; Escudero-Cernuda S; Sendon-Lago J; Gonzalez LO; Fernandez-Sánchez ML; Vizoso FJ
Stem Cell Res Ther; 2024 Apr; 15(1):121. PubMed ID: 38664697
[TBL] [Abstract] [Full Text] [Related]
2. The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis.
Cui M; Dong H; Duan W; Wang X; Liu Y; Shi L; Zhang B
PeerJ; 2024; 12():e16958. PubMed ID: 38410801
[TBL] [Abstract] [Full Text] [Related]
3. Dual effect of vitamin D
Łabędź N; Anisiewicz A; Stachowicz-Suhs M; Banach J; Kłopotowska D; Maciejczyk A; Gazińska P; Piotrowska A; Dzięgiel P; Matkowski R; Wietrzyk J
BMC Cancer; 2024 Feb; 24(1):209. PubMed ID: 38360633
[TBL] [Abstract] [Full Text] [Related]
4. The obeticholic acid can positively regulate the cancerous behavior of MCF7 breast cancer cell line.
Rahmani R; Eivazi N; Emamgholipour S; Aminian M; Jalilian A; Paknejad M
Mol Biol Rep; 2024 Feb; 51(1):250. PubMed ID: 38302816
[TBL] [Abstract] [Full Text] [Related]
5. Prediction of gastrointestinal symptoms trajectories using omega-3 and inflammatory biomarkers in early-stage breast cancer patients receiving chemotherapy.
Arcos D; Ng DQ; Ke Y; Toh YL; Chan A
Support Care Cancer; 2024 Jan; 32(1):76. PubMed ID: 38170327
[TBL] [Abstract] [Full Text] [Related]
6. n-3 PUFAs synergistically enhance the efficacy of doxorubicin by inhibiting the proliferation and invasion of breast cancer cells.
Gurav P; Patade T; Hajare S; Kedar RN
Med Oncol; 2023 Nov; 41(1):2. PubMed ID: 38017288
[TBL] [Abstract] [Full Text] [Related]
7. Tetracaine downregulates matrix metalloproteinase activity and inhibits invasiveness of strongly metastatic MDA-MB-231 human breast cancer cells.
Keleş D; Sipahi M; İnanç-Sürer Ş; Djamgoz MB; Oktay G
Chem Biol Interact; 2023 Nov; 385():110730. PubMed ID: 37806380
[TBL] [Abstract] [Full Text] [Related]
8. Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative breast cancer Cells.
Agnello L; d'Argenio A; Caliendo A; Nilo R; Zannetti A; Fedele M; Camorani S; Cerchia L
Cells; 2023 Jul; 12(13):. PubMed ID: 37443843
[TBL] [Abstract] [Full Text] [Related]
9. The cytotoxic effects of indoleamine 2, 3-dioxygenase inhibitors on triple negative breast cancer cells upon tumor necrosis factor α stimulation.
Bilir C; Eskiler GG; Bilir F
J Cancer Res Ther; 2023 Apr; 19(Supplement):S74-S80. PubMed ID: 37147986
[TBL] [Abstract] [Full Text] [Related]
10. The Potential of DHA as cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials.
de Freitas Rodrigues J; Philippsen HK; Dolabela MF; Nagamachi CY; Pieczarka JC
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111226
[TBL] [Abstract] [Full Text] [Related]
11. Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human breast cancer Cells.
Ianni A; Ruggeri P; Bellio P; Martino F; Celenza G; Martino G; Franceschini N
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500603
[TBL] [Abstract] [Full Text] [Related]
12. Oncoinformatic screening of the gene clusters involved in the HER2-positive breast cancer formation along with the in silico pharmacodynamic profiling of selective long-chain omega-3 fatty acids as the metastatic antagonists.
Morshed AKMH; Al Azad S; Mia MAR; Uddin MF; Ema TI; Yeasin RB; Srishti SA; Sarker P; Aurthi RY; Jamil F; Samia NSN; Biswas P; Sharmeen IA; Ahmed R; Siddiquy M; Nurunnahar
Mol Divers; 2023 Dec; 27(6):2651-2672. PubMed ID: 36445532
[TBL] [Abstract] [Full Text] [Related]
13. Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer.
Bailly C
Eur J Pharmacol; 2022 Sep; 931():175191. PubMed ID: 35964660
[TBL] [Abstract] [Full Text] [Related]
14. The Predictive Role of MMP-2, MMP-9, timp-1 and timp-2 Serum Levels in the Complete Response of the Tumor to Chemotherapy in breast cancer Patients.
Ozdemir K; Zengin I; Guney Eskiler G; Kocer HB; Ozkan AD; Demiray T; Sahin EO
J Invest Surg; 2022 Jul; 35(7):1544-1550. PubMed ID: 35636767
[TBL] [Abstract] [Full Text] [Related]
15. Assessment of iron metabolism disorders and adequate treatment of anemic syndrome in patients with breast cancer on the background of adjuvant chemotherapy.
Blindar VN; Zubrikhina GN; Davydova TV; Dobrovolskaya MM; Khagazheeva MN; Snegovoy AV; Lyubimova NV; Kushlinskii NE; Ryabchikov DA
Klin Lab Diagn; 2022 Apr; 67(4):213-218. PubMed ID: 35575394
[TBL] [Abstract] [Full Text] [Related]
16. Evening Primrose Oil Enhances Tamoxifen's Anticancer Activity against breast cancer Cells by Inducing Apoptosis, Inhibiting Angiogenesis, and Arresting the Cell Cycle.
Abd-Alhaseeb MM; Massoud SM; Elsayed F; Omran GA; Salahuddin A
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458590
[TBL] [Abstract] [Full Text] [Related]
17. Therapeutic Effects of Mesenchymal Stem Cells Expressing Erythropoietin on cancer-Related Anemia in Mice Model.
Estiri M; Estiri B; Fallah A; Aghazadeh M; Sedaqati A; Abdollahi A; Rabienia M; Mortazavidehkordi N; Farjadfar A
Curr Gene Ther; 2022; 22(5):406-416. PubMed ID: 35382717
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic Value of Nonacid Nucleic Blood Tumor Marker Panels in Early Diagnosing breast cancer: A Systematic Review and Network Meta-Analysis.
Raja V; Farajzadegan Z; Mansourian M; Ghasemi K; Aboutalebi MS; Nouri R; Mokarian F
Dis Markers; 2022; 2022():4119345. PubMed ID: 35222743
[TBL] [Abstract] [Full Text] [Related]
19. Dietary omega-3 fatty acid intake impacts peripheral blood DNA methylation -anti-inflammatory effects and individual variability in a pilot study.
Frankhouser DE; Steck S; Sovic MG; Belury MA; Wang Q; Clinton SK; Bundschuh R; Yan PS; Yee LD
J Nutr Biochem; 2022 Jan; 99():108839. PubMed ID: 34411715
[TBL] [Abstract] [Full Text] [Related]
20. A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers.
Kucuksayan E; Bozkurt F; Yilmaz MT; Sircan-Kucuksayan A; Hanikoglu A; Ozben T
Sci Rep; 2021 Jun; 11(1):13027. PubMed ID: 34158544
[TBL] [Abstract] [Full Text] [Related]
[Next]
